Lord, Abbett & Co’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-87,981
| Closed | -$2.95M | – | 587 |
|
|
2025
Q1 | $2.95M | Sell |
87,981
-106,990
| -55% | -$3.59M | 0.01% | 496 |
|
|
2024
Q4 | $7.64M | Buy |
194,971
+20,986
| +12% | +$823K | 0.02% | 421 |
|
|
2024
Q3 | $6.85M | Sell |
173,985
-16,048
| -8% | -$632K | 0.02% | 444 |
|
|
2024
Q2 | $7.41M | Sell |
190,033
-705,163
| -79% | -$27.5M | 0.02% | 420 |
|
|
2024
Q1 | $38.5M | Buy |
895,196
+177,224
| +25% | +$7.63M | 0.12% | 220 |
|
|
2023
Q4 | $33.1M | Sell |
717,972
-431,196
| -38% | -$19.9M | 0.12% | 239 |
|
|
2023
Q3 | $39.3M | Sell |
1,149,168
-809,372
| -41% | -$27.6M | 0.15% | 202 |
|
|
2023
Q2 | $75.4M | Buy |
1,958,540
+175,929
| +10% | +$6.77M | 0.26% | 117 |
|
|
2023
Q1 | $63.8M | Sell |
1,782,611
-341,398
| -16% | -$12.2M | 0.23% | 141 |
|
|
2022
Q4 | $83.7M | Buy |
2,124,009
+210,148
| +11% | +$8.29M | 0.3% | 86 |
|
|
2022
Q3 | $69.1M | Buy |
1,913,861
+56,265
| +3% | +$2.03M | 0.25% | 105 |
|
|
2022
Q2 | $56.5M | Buy |
1,857,596
+66,853
| +4% | +$2.03M | 0.2% | 145 |
|
|
2022
Q1 | $54.7M | Sell |
1,790,743
-4,337
| -0.2% | -$133K | 0.15% | 199 |
|
|
2021
Q4 | $56.1M | Buy |
1,795,080
+1,416,722
| +374% | +$44.3M | 0.13% | 237 |
|
|
2021
Q3 | $5.78M | Sell |
378,358
-6,367
| -2% | -$97.3K | 0.01% | 581 |
|
|
2021
Q2 | $7.16M | Sell |
384,725
-33,825
| -8% | -$630K | 0.02% | 579 |
|
|
2021
Q1 | $7.49M | Buy |
+418,550
| New | +$7.49M | 0.02% | 562 |
|